16-19536181-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001323572.2(CCP110):c.512C>T(p.Pro171Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,613,600 control chromosomes in the GnomAD database, including 13,971 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001323572.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCP110 | NM_001323572.2 | c.512C>T | p.Pro171Leu | missense_variant | 4/14 | ENST00000694978.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCP110 | ENST00000694978.1 | c.512C>T | p.Pro171Leu | missense_variant | 4/14 | NM_001323572.2 | P4 |
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24428AN: 151916Hom.: 2913 Cov.: 32
GnomAD3 exomes AF: 0.147 AC: 37037AN: 251278Hom.: 4598 AF XY: 0.137 AC XY: 18550AN XY: 135816
GnomAD4 exome AF: 0.0967 AC: 141351AN: 1461566Hom.: 11041 Cov.: 32 AF XY: 0.0962 AC XY: 69975AN XY: 727088
GnomAD4 genome AF: 0.161 AC: 24476AN: 152034Hom.: 2930 Cov.: 32 AF XY: 0.164 AC XY: 12199AN XY: 74310
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at